Chinese Medicine and Immunity

  • Haruhisa Wago
  • Hong Deng
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 546)


Traditional Chinese Medicine (TCM) has so far been known to be useful for cancer patients as both an anti-tumor and an immuno-enhancing drug 1,2. If some kinds of crude drugs of TCM possess such biological activities, they would be of great help in cancer treatment. Recently, it was found that Astragali radix has immuno-enhancing and anti-tumor effects3–5 and Angelicae radix also has anti-inflammatory, analgestic, interferon-inducing, and immunopotentiating effects6–9. In addition, Zizyphi fructus is reported to augment the natural killer cell activity10, while Cervi parvum cornu is shown to exert anti-tumor effects by the inhibition of monoamine oxidase11–13. Amomi semen and Rehmanniaee radix are also known to have anti-tumor activity and to enhance the function of cytotoxic T lymphocyte with the increase of IL-214,15.


Natural Killer Cell Traditional Chinese Medicine Peripheral Blood Lymphocyte Natural Killer Cell Activity Crude Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    I. Adachi and T. Watanabe, Gan To Kagaku. 16, 1538 (1989).Google Scholar
  2. 2.
    Y.S. Lee, I.S. Chung, I.R. Lee, K.H. Kin, W.S. Hong and Y.S. Yun, Anticancer Res. 17, 323 (1997).PubMedGoogle Scholar
  3. 3.
    K.S. Zhao, C. Mancini and G. Doria, Immunophamacol. 20, 225 (1990).CrossRefGoogle Scholar
  4. 4.
    Y. Yoshida, M.Q. Wang, J.N. Liu, B.E. Shan and U. Yamashita, Int. J. Immunophamacol. 19, 359 (1997).CrossRefGoogle Scholar
  5. 5.
    B.H. Lau, H.C. Botolazzo and P.D. Lui, Cancer Biotherpy. 9, 153 (1994).CrossRefGoogle Scholar
  6. 6.
    S. Kojima, K. Inaba, S. Kobayashi and M. Kimura, Biol. Pharm. Bull. 19, 47 (1996).PubMedCrossRefGoogle Scholar
  7. 7.
    S. Tanaka, Y. Ikeshiro, M. Tabata and M. Konoshima, Arzneimittelforschung. 27, 2039 (1977).Google Scholar
  8. 8.
    Y. Kumazawa, Y. Nakatsuru, H. Fujisawa, C. Nishimura, K. Mizunoe and Y. Otsuka, J. Pharmacobiodyn. 8, 417 (1985).PubMedCrossRefGoogle Scholar
  9. 9.
    N.L. Wang, H. Kiyohara, T. Matsumoto, H. Otsuka, M. Hirano and H. Yamada, Planta Med. 60, 425 (1994).PubMedCrossRefGoogle Scholar
  10. 10.
    Y. Yamaoka, T. Kawakita, M. Kaneko and K. Nomoto, Biol. Pharm. Bull. 19, 936 (1996).PubMedCrossRefGoogle Scholar
  11. 11.
    B.X. Wang, X.H. Zhao, S.B. Qi, S. Kaneko, M. Hattori and T. Namba, Chem. Pharm. Bull, 36, 2587 (1988).PubMedCrossRefGoogle Scholar
  12. 12.
    B.X. Wang, A.J. Liu, Q.G. Wang, G.R. Wei, J.C. Chui and N. Yang, Chinese Dispatches Pharmacol. 3, 9 (1985).Google Scholar
  13. 13.
    X.B. Sun and C.C. Zhou, Chinese Patent Pedicine Res. 2, 24 (1986).Google Scholar
  14. 14.
    M. Hamada, Y. Fujii, H. Yamamoto, Y. Miyazawa, S.M. Shui and Y.C. Tung, J. Ethnopharmacol. 24, 311 (1988).PubMedCrossRefGoogle Scholar
  15. 15.
    L.Z. Chen and X.W. Zhou, Chung Kuo Yao Li Hsuch Pao. 16, 337 (1995).Google Scholar
  16. 16.
    H. Deng, K. Nakajima, X. Ma, K. Hasumi, T. Akatsuka and H. Wago, J. Saitama Med. School. 28, 109 (2001).Google Scholar
  17. 17.
    K. Nakajima, H. Deng, X. Ma, K. Hasumi, T. Akatsuka and H. Wago, J. Saitama Med. School. 28, 117 (2001).Google Scholar
  18. 18.
    H. Deng, K. Nakajima, X. Ma, K. Hasumi, T. Akatsuka and H. Wago, J. Saitama Med. School. 28, 125 (2001).Google Scholar
  19. 19.
    C.F. Nathan, Clin. Invest. 79, 319 (1987).CrossRefGoogle Scholar
  20. 20.
    P. Alexander and R. Evans, Nat. New Biol. 232, 76 (1971).PubMedGoogle Scholar
  21. 21.
    R.B. Johnston, C.A. Godzik and Z.A. Cohn, J. Exp. Med. 148, 115 (1978).PubMedCrossRefGoogle Scholar
  22. 22.
    F. Amano and Y. Akamatsu, Infect Immun. 59, 2126 (1991).Google Scholar
  23. 23.
    T. Noda and F. Amano, Biol. Pharm. Bull. 21, 673 (1998).PubMedCrossRefGoogle Scholar
  24. 24.
    D. Salvemini, A. Pistelli, V. Mollace, E. Anggard and J. Vane, Biochem. Pharmacol. 44, 17 (1992).PubMedCrossRefGoogle Scholar
  25. 25.
    F. Kura, K. Suzuki, H. Watanabe, Y. Akamatsu and F. Amano, Infect Immun. 62, 5419 (1994).PubMedGoogle Scholar
  26. 26.
    M. Fujikura, M. Muroi, Y. Muroi, N. Ito and T. Suzuki, J. Biol. Chem. 268, 14898 (1993).Google Scholar
  27. 27.
    J. Klostergaard, W.A. Foster and M.E. Leroux, J. Biol. Response Mod. 6, 313 (1987).PubMedGoogle Scholar
  28. 28.
    K. Kawakami, M.H. Qureshi, Y. Koguchi, K. Nakajima and A. Saito, FEMS Microbiol. Lett. 175, 87 (1999).PubMedCrossRefGoogle Scholar
  29. 29.
    M.G. Lei and D.C. Morrison, Infect Immun. 68, 5084 (2000).PubMedCrossRefGoogle Scholar
  30. 30.
    R. Manetti, P. Parronchi, M.G. Piccinni, E. Maggi and G. Trinchieri, J. Exp. Med. 177, 1199 (1993).PubMedCrossRefGoogle Scholar
  31. 31.
    T. Kato, R. Hakamada, H. Yamane and H. Nariuchi, J. Immunol. 156, 3932 (1996).PubMedGoogle Scholar
  32. 32.
    U. Shu, M. Kiniwa, C.Y. Wu, C. Maliszewski, N. Vezzio and J. Hakimi, Eurp. J. Immunol. 25, 1125 (1995).CrossRefGoogle Scholar
  33. 33.
    T. Kato, H. Yamane and H. Nariuchi, Cell. Immunol. 181, 59 (1997).PubMedCrossRefGoogle Scholar
  34. 34.
    C.S. Hsieh, S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O’Garra and K.M. Murphy, Science. 260, 547 (1993).PubMedCrossRefGoogle Scholar
  35. 35.
    E.J. Roy, U. Gawlick, B.A. Orr, L.A. Rund and A.G. Kranz, J. Immunol. 165, 7293 (2000).PubMedGoogle Scholar
  36. 36.
    M.J. Smith, M. Taniguchi and S.E. Street, J. Immunol. 165, 2665 (2000).Google Scholar
  37. 37.
    K. Takeda, Y. Hayakawa, M. Atsuta, S. Hong, L. van Kaer and K. Kobayashi, Int. Immunol. 12, 909 (2000).PubMedCrossRefGoogle Scholar
  38. 38.
    R.J. Armitage, A.E. Namen, H.M. Sassenfeld and K.H. Grabstein, J. Immunol. 144, 938 (1990).PubMedGoogle Scholar
  39. 39.
    A.L. Causey, R.M. Wooten, L.W. Clem and J.E. Bly, J. Immunol. Methods. 175, 115 (1994).PubMedCrossRefGoogle Scholar
  40. 40.
    T.R. Mosmann and R.L. Coffman, Ann. Rev. Immunol. 7, 145 (1989).CrossRefGoogle Scholar
  41. 41.
    Y. Tanaka, H. Eda, T. Tanaka, T. Udagawa, T. Ichikawa and I. Horii, Cancer Res. 50, 2290 (1990).PubMedGoogle Scholar
  42. 42.
    T.H. Corbett, D.P. Griswold, B.J. Roberts, J.C. Peckham and F.M. Schabe, Cancer Res. 35, 2434 (1975).PubMedGoogle Scholar
  43. 43.
    S. Sakaguchi, E. Tsutsumi and K. Yokota, Biol. Pharm. Bull. 16, 782 (1993).PubMedCrossRefGoogle Scholar
  44. 44.
    S. Sakaguchi, S. Furusawa, K. Yokota, K. Sasaki and Y. Takayanagi, Biol. Pharm. Bull. 18, 621 (1995).PubMedCrossRefGoogle Scholar
  45. 45.
    K. Terasaki, M. Nose and Y. Ogiwara, Biol. Pharm. Bull. 20, 809 (1997).CrossRefGoogle Scholar
  46. 46.
    W.D. DeWys, D. Gegg, P.T. Lavin, P.R. Band J.M. Bennett, Am. J. Med. 69, 491 (1980).PubMedCrossRefGoogle Scholar
  47. 47.
    K. Soda, M. Kawakami, A. Kashii and M. Miyata, Jpn. J. Cancer Res. 85, 1124 (1994).PubMedCrossRefGoogle Scholar
  48. 48.
    G. Trinchieri, Adv. Immunol. 47, 187 (1989).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Haruhisa Wago
    • 1
  • Hong Deng
    • 2
  1. 1.Department of Medical TechnologySaitama Medical School Junior CollegeSaitamaJapan
  2. 2.Electro-Chemical & Cancer InstituteChofu, TokyoJapan

Personalised recommendations